Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.

Clin Mol Hepatol · 2014 · PMC4197175 · PMID 25320730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

These results were in agreement with those in recent reports which showed a trend toward an improved virologic response in the add-on ADV group than in the ETV group. 13 , 14 , 15 The explanation of the different virologic response between the two groups was the presence of HBV strains with limited sensitivity to ETV.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.